跳至主要内容
临床试验/EUCTR2009-015849-22-GB
EUCTR2009-015849-22-GB进行中(未招募)1 期

An open label study of intra-articular steroid injection in the management of symptomatic knee OA - TArgeting Synovitis in Knee OA (TASK) V1.0

Salford Royal Foundation NHS Trust0 个研究点目标入组 120 人开始时间: 2010年3月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age 40 years and over
  • Symptomatic Knee OA (moderate knee pain or discomfort lasting 48 hours in the past 2 weeks and/or KOOS score of 7 and above)
  • Within the last 24 months - Radiological (X-ray) evidence of grade 2 or more OA; evidence of significant OA on MRI scan; documented evidence of at least grade 2 arthritis on arthroscopy.
  • Able and willing to comply with intervention and follow up
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Secondary OA - septic arthritis, gout
  • History of inflammatory arthritis
  • Previous knee surgery or arthroscopy within 6 months
  • Previous intra-articular Ostenil or steroid injection within 3 months
  • Inability to comply with the study procedures
  • Chronic Kidney Disease (eGFR <=44)
  • Concurrent life threatening disease
  • Implants which prohibit safe use of MRI (eg.Cochlear implants)
  • Known hypersensitivity to Depomedrone or any components of its excipients
  • Systemic infection (unless specific anti infective therapy is employed)

研究者

发起方
Salford Royal Foundation NHS Trust

相似试验